Home Shares & Financial Investing in CBD oil stocks interesting? The 8 most popular cannabis stocks that are currently booming.

Investing in CBD oil stocks interesting? The 8 most popular cannabis stocks that are currently booming.

through druginc

Are you interested in investing in CBD oil stocks? The 8 most popular CBD and cannabis stocks that are booming.

Before we get into the discussion about investing in CBD (or cannabidiol) oil stocks, it may be helpful to first look at the potential health benefits of this CBD oil. This will allow shareholders to better understand why many are venturing into this investment.

Several studies have shown that CBD oil:

  • Helps reduce the risk of developing diabetes
  • Helps fight cancer
  • Fighting fear
  • Helps with chronic pain relief

In fighting cancer, for example, CBD provides an anti-tumor effect that promotes the death of tumor cells in leukemia and colon cancer. Another study showed that this phytocannabinoid can help stop the spread of cancer cells in the case of, for example, cervical cancer.

It also has anti-epileptic properties, which was supported by a random, placebo-controlled study. The study showed that CBD has an anti-epileptic effect on young adults with Dravet's syndrome.

This condition is a form of epilepsy in which patients experience convulsions caused by fever. Patients treated with CBD had a median decrease in seizures of 38,9%.

It can also be an add-on treatment for Crohn's disease, an inflammatory bowel disease that affects the gastrointestinal tract. An Israeli study found that those who took it for two months experienced reduced symptoms and a better quality of life.

CBD oil or hemp oil is unique because it is non-psychoactive. This means that it does not have the same effect as using cannabis, so you will not experience a “high”.

Why is investing in CBD oil stocks interesting?

The biggest question an investor may have before entering the marijuana business is whether it is safe to buy cannabis stocks. While there is no way to guarantee how a particular stock will perform as usual, investors can still use very effective techniques to analyze the potential market movement.

Medical demand for CBD oils aside, stock market growth could increase 2020% by 700, with a compound annual growth rate (CAGR) of 11%. Even more impressive is the fact that it could surpass $ 2021 billion by 3.

In addition, with the number of recreational marijuana users switching to CBD, it may even be possible to reach these figures earlier. As states in America begin to legalize cannabis use, demand for the plant continues to rise.

Hemp Business Journal, a leading hemp research organization, confirmed this when their marketing research team analyzed trends in the marijuana industry.

Moreover, many large companies have achieved great success in their investments with medicinal cannabis. This is a good sign that investing in CBD oil stocks may be worth a try.

What are some of the leading CBD oil stocks to keep an eye out for in 2019?

After learning about the benefits of investing in CBD oil stocks, it's time to find out which CBD companies are worth the time and money. These leading cannabis stocks may be worth considering in an investor's portfolio.

1. Terra Tech Corp (OTCMKTS: TRTC)

It is a retail cannabis company that "hopes" to dominate the California cannabis market. As of April 2018, their market cap is about $ 11 million making them one of the largest companies to watch.

For the third quarter of 2018, shareholders of the company had equity of approximately $ 93,1 million. This means an increase of approximately $ 16,3 million compared to the equity of the last quarter of 2017, which was only $ 76,8 million.

2. Kush Bottles (OTCMKTS: KSHB)

Like Terra Tech Corp, Kush Bottles is also a California-based company. Initially, they started as a packaging company that soon turned to the cannabis industry.
A comparison of equity from 31 August 2017 ($ 40,9 million) to 31 May 2018 ($ 72,3 million) showed a huge increase of more than $ 30 million.

3. 1933 Industries Inc. (TGIF: CNX)

1933 Industries Inc., formerly known as Friday Night Inc., has a large number of cannabis wellness products that many users purchase for medical purposes.

Data also shows the success of the company:

  • Increase in turnover - For the three-month period ended July 31, 2018, the company saw sales increase of 18% from $ 3,3 million CAD to $ 3,9 million CAD.
  • Equity - They also enjoyed an increase in equity for 2018. For July, they had $ 36,9 million CAD, which increased to $ 41,4 CAD in October.

4. GW Pharmaceuticals (NASDAQ: GWPH)

One of the pioneers in the CBD and marijuana industry is GW Pharmaceuticals. They are a well-known British pharmaceutical company offering Nabiximols, the first drug derived from a cannabis plant for multiple sclerosis to gain market authorization in every country.
It started in 1998 as a public limited company. Today it has a public offering on American Depository Shares and Nasdaq Global Market.

Data showed that as of the last quarter of 2018, which ended December 31, the company has equity of $ 674,08 million. This revealed a big increase from the previous quarter of the same year ending September 30, bringing in “only” $ 415,16 million.

5. Aurora Cannabis Inc. (TSE: ACB)

This company is a Canadian cannabis supplier with a license. It has a public offer on the Toronto Stock Exchange as ACB.

Starting from 2018, it has five sales licenses and eight production facilities in 18 countries around the world. In 2017, it generated approximately $ 13,5 million in revenue.

Equity for the last quarter of 2018 amounted to CAD $ 4,22 billion, a decrease compared to the previous quarter of the same year, which amounted to CAD 4,4 billion.

With its impressive performance, it is no wonder that many analysts have investors looking out for Aurora Cannabis Inc. this year.

6. Isodoil Inc. (CSE: ISOL)

Isodiol Inc. is known worldwide as one of the largest providers of industrial hemp and CBD products and continues to raise awareness of the medical benefits of cannabis-derived products. Their goal as a company is not only to sell their products, but to educate the masses about the use of medical marijuana.

The company experienced sales growth of a staggering 5.276% in a one-year period from March 31, 2017 to March 31, 2018, from $ 355.959 to over $ 19 million US dollars.

7. Canopy Growth Corp. (TSE: WEED)

Formerly Tweed Marijuana Inc. the company has adopted the name Canopy Growth Corporation in 2015. The Tweed brand is growing rapidly all over the world.
In fact, The Motley Fool called it one of the best marijuana stocks to watch out for coming 2019. The sales and popularity give it a head start on its competitors in the market.

For their equity, they had CAD $ 7,2 billion for the last quarter of 2018, which was a significant increase in the previous three quarters of the same year, reaching $ 1,15 billion, CAD $ 1,13 billion, CAD $ 1,6 billion, respectively.

8. Golden Leaf Holdings Ltd. (CNSX: GLH)

This Portland-based company is currently one of the largest suppliers of CBD oil in North America. They are proud to be a results-oriented brand that focuses on meeting the needs of their customers.

For Q3 2018, the company reported sales of $ 5.1. million, an increase of 63% compared to the $ 3,1 million of the third quarter of 2017.

Remark: These are just some of the best CBD oil stocks to invest in according to Profit Confidential. Feel free to discover other CBD companies that you might find even more impressive.

What are the opportunities and challenges when investing in CBD?

Investors can make a thorough decision when it comes to investing in hemp or CBD shares if they have more knowledge about the outlook for the sector. For that it is good to look at the opportunities and challenges.

1. Nutrition trends

Hemp CBD will go beyond the dispensaries. Today, chefs already consider it one of the top food trends for 2019, according to a survey by the National Restaurant Association.

Restorers add food to the oil, not only to improve taste, but also to give in to consumer demand.

The cannabis-infused beverage market could grow to more than $ 2024 billion by 1, 15 times more than its value in 2018. Companies like Life on Earth and Canopy Growth are likely to lead the way.

However, regulation remains a challenge. New York, for example, is already busy with rules regarding the use of such cannabis products, especially in food.

2. Legalization of cannabis

Marijuana growers may have more reason to rejoice. More states are planning to legalize the sale of such products even for recreational use.

Illinois recently passed a bill that allows medical dispensaries and pharmacies to sell recreational weed. They also allow them to open a second location, possibly doubling their number by next year.

In Mexico the subject of cannabis use, sales and production remains controversial. Medical marijuana or cannabis is legal, while the recreational species is not.

However, those considering investing in CBD and weed in the country can take the case law into account. Since 2015, the Supreme Court had already ruled that growing cannabis for recreation was unconstitutional.

This does not mean that products for recreational use are legal, but they can go to the federal court for help.

3. FDA and DEA perspectives in the US

Unlike marijuana, CBD products are legal under the Farm Bill law, which re-registered hemp from a controlled substance. Likewise, investing in CBD stocks and even ETFs in the United States is legal.

However, the hemp industry finds a tough battle with the Food and Drug Administration (FDA). It continues to exercise authority over the regulation of CBD or hemp-based products.

According to this FDA in America, CBD is still a drug ingredient, and so products containing it should still go through the approval process. However, note that the FDA has previously approved a drug containing CBD called Epidiolex, which is for seizures.

So far, both camps, the sellers and the FDA, hold hearings. Those who sell such products hope that the FDA agency in America will relax regulation.

Meanwhile, the Drug Enforcement Agency (DEA) classified cannabis-derived drugs that are FDA-approved and contain less than 0,1% THC as Schedule 5. This means they are legal as long as use is based on a doctor's prescription.

Investing in CBD oil stocks is definitely an option that is worth exploring if you are looking to add it to your investment portfolio. The market is growing due to strong medical requirements with only a few companies active in the industry so far.

Perhaps the best thing you can do as a potential marijuana stock investor is to do sensible research first and then always invest with your eyes open. Like any other kind of stock, always analyze the industry with an open mind to effectively predict potential market trends in the future.

Read more at Herostocks (EN, source)

Related Articles

Comments